Jefferies Group Trims U.S. Physical Therapy Inc. (USPH) Target Price to $60.00
Other equities research analysts have also issued reports about the company. Zacks Investment Research lowered U.S. Physical Therapy from a buy rating to a hold rating in a research note on Wednesday, August 3rd. Barrington Research lowered U.S. Physical Therapy from an outperform rating to a market perform rating in a research note on Friday, August 5th.
U.S. Physical Therapy (NYSE:USPH) opened at 56.70 on Monday. U.S. Physical Therapy has a 12-month low of $45.62 and a 12-month high of $64.89. The stock has a market cap of $709.94 million, a P/E ratio of 29.38 and a beta of 0.85. The stock has a 50 day moving average price of $60.62 and a 200 day moving average price of $59.70.
U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Thursday, November 3rd. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.49 by $0.03. The company earned $88.30 million during the quarter, compared to analysts’ expectations of $33.94 million. U.S. Physical Therapy had a return on equity of 11.54% and a net margin of 6.84%. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter last year, the company earned $0.47 earnings per share. On average, analysts forecast that U.S. Physical Therapy will post $1.93 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 2nd. Shareholders of record on Friday, November 18th will be issued a dividend of $0.17 per share. The ex-dividend date is Wednesday, November 16th. This represents a $0.68 dividend on an annualized basis and a yield of 1.20%. U.S. Physical Therapy’s dividend payout ratio is presently 35.05%.
In other U.S. Physical Therapy news, CFO Lawrance W. Mcafee sold 2,000 shares of the firm’s stock in a transaction dated Monday, September 19th. The stock was sold at an average price of $64.00, for a total transaction of $128,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Christopher J. Reading sold 8,000 shares of the firm’s stock in a transaction dated Monday, September 19th. The shares were sold at an average price of $64.01, for a total value of $512,080.00. The disclosure for this sale can be found here. Company insiders own 4.30% of the company’s stock.
Large investors have recently bought and sold shares of the stock. Bank of Montreal Can acquired a new stake in U.S. Physical Therapy during the second quarter worth approximately $14,047,000. Aberdeen Asset Management PLC UK raised its position in shares of U.S. Physical Therapy by 65.3% in the second quarter. Aberdeen Asset Management PLC UK now owns 321,707 shares of the company’s stock worth $19,370,000 after buying an additional 127,094 shares during the last quarter. Prudential Financial Inc. raised its position in shares of U.S. Physical Therapy by 9.8% in the first quarter. Prudential Financial Inc. now owns 31,870 shares of the company’s stock worth $1,585,000 after buying an additional 2,850 shares during the last quarter. Ameriprise Financial Inc. raised its position in shares of U.S. Physical Therapy by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 78,338 shares of the company’s stock worth $4,717,000 after buying an additional 436 shares during the last quarter. Finally, HBK Investments L P purchased a new position in shares of U.S. Physical Therapy during the first quarter worth $403,000. 93.51% of the stock is currently owned by institutional investors and hedge funds.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.